BN Business News
Add your company to Business Communicator →

Business · 22/11/20261 min read

TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Late-breaking 6-month full cohort data presented at PCR London Valves 2026 shows durable tricuspid regurgitation reduction up to 3 years, positive right heart remodeling and quality-of-life improvements, as the company advances its CE Mark application. LONDON, Nov. 22, 2026 /PRNewswire/...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →